相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The influence of tetracyclines on T cell activation
M. KLOPPENBURG et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Prion protein misfolding and disease
Roger A. Moore et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2009)
Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease
Wendy Noble et al.
FASEB JOURNAL (2009)
The Parkinson Disease Protein Leucine-Rich Repeat Kinase 2 Transduces Death Signals via Fas-Associated Protein with Death Domain and Caspase-8 in a Cellular Model of Neurodegeneration
Cherry Cheng-Ying Ho et al.
JOURNAL OF NEUROSCIENCE (2009)
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Juha Lauren et al.
NATURE (2009)
Molecular basis of Parkinson's disease
Yan Xiang Yang et al.
NEUROREPORT (2009)
Protein misfolding and neurodegeneration
Claudio Soto et al.
ARCHIVES OF NEUROLOGY (2008)
Programmed cell death mechanisms in neurological disease
Dale E. Bredesen
CURRENT MOLECULAR MEDICINE (2008)
Antibody-based approaches in Alzheimer's research: safety, pharmacokinetics, metabolism, and analytical tools
Peter Lichtlen et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Mechanisms of minocycline-induced suppression of simian immunodeficiency virus encephalitis: inhibition of apoptosis signal-regulating kinase 1
Susan C. Follstaedt et al.
JOURNAL OF NEUROVIROLOGY (2008)
Minocycline for patients with ALS
Peter N. Leigh et al.
LANCET NEUROLOGY (2008)
A possible link between astrocyte activation and tau nitration in Alzheimer's disease
Juan F. Reyes et al.
NEUROBIOLOGY OF DISEASE (2008)
Aggregopathy in neurodegenerative diseases: Mechanisms and therapeutic implication
C. P. Dohm et al.
NEURODEGENERATIVE DISEASES (2008)
Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
Scott A. Small et al.
NEURON (2008)
Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: Involvement of endoplasmic reticulum calcium release in oligomer-induced cell death
R. Resende et al.
NEUROSCIENCE (2008)
Limited minocycline neuroprotection after balloon-compression spinal cord injury in the rat
Kamila Saganova et al.
NEUROSCIENCE LETTERS (2008)
The Efficacy of Tetracyclines in Peripheral and Intracerebral Prion Infection
Ada De Luigi et al.
PLOS ONE (2008)
Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma
Alejandra Bosco et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Minocycline, a possible neuroprotective agent in Leber's hereditary optic neuropathy (LHON):: Studies of cybrid cells bearing 11778 mutation
Mohammad Fahad Haroon et al.
NEUROBIOLOGY OF DISEASE (2007)
Neuronal apoptosis in neurodegeneration
Masahiro Okouchi et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration
Maya G. Purisai et al.
NEUROBIOLOGY OF DISEASE (2007)
Lack of minocycline efficiency in genetic models of Huntington's disease
Stephane Mievis et al.
NEUROMOLECULAR MEDICINE (2007)
C1q binding and complement activation by prions and amyloids
Robert B. Sim et al.
IMMUNOBIOLOGY (2007)
Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease
John P. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP
Angelika S. Rambold et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations
Conrad C. Alano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Amyloid fibrils of mammalian prion protein are highly toxic to cultured cells and primary neurons
V Novitskaya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Minocycline affects microglia activation, Aβ deposition, and behavior in APP-tg mice
TJ Seabrook et al.
GLIA (2006)
Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline
MJ Casarejos et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice
EC Stack et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2006)
Inhibitory effect of minocycline on amyloid β fibril formation and human microglial activation
A Familian et al.
GLIA (2006)
Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease
J. K. Ryu et al.
NEUROSCIENCE (2006)
Effects of minocycline on Fas-mediated fulminant hepatitis in mice
HC Chu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Minocycline fails to protect cerebellar granular cell cultures against malonate-induced cell death
FJ Fernandez-Gomez et al.
NEUROBIOLOGY OF DISEASE (2005)
Minocycline as a neuroprotective agent
DP Stirling et al.
NEUROSCIENTIST (2005)
Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease
AL Guillozet-Bongaarts et al.
NEUROBIOLOGY OF AGING (2005)
Tau, tangles, and Alzheimer's disease
LI Binder et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Clinical potential of minocycline for neurodegenerative disorders
D Blum et al.
NEUROBIOLOGY OF DISEASE (2004)
Inefficient degradation of truncated polyglutamine proteins by the proteasome
CI Holmberg et al.
EMBO JOURNAL (2004)
Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease
E Diguet et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Failure of neuronal protection by inhibition of glial activation in a rat model of striatonigral degeneration
N Stefanova et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein
C Hetz et al.
EMBO JOURNAL (2003)
Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease
X Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Minocycline and doxycycline are not beneficial in a model of Huntington's disease
DL Smith et al.
ANNALS OF NEUROLOGY (2003)
Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms
C Andorfer et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Minocycline blocks 6-hydroxydopamine-induced neurotoxicity and free radical production in rat cerebellar granule neurons
SZ Lin et al.
LIFE SCIENCES (2003)
Tetracyclines affect prion infectivity
G Forloni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Minocycline slows disease progression in a mouse model of arnyotrophic lateral sclerosis
J Kriz et al.
NEUROBIOLOGY OF DISEASE (2002)
Minocycline delays disease onset and mortality in a transgenic model of ALS
L Van Den Bosch et al.
NEUROREPORT (2002)
Targeting leukocyte MMPs and transmigration - Minocycline as a potential therapy for multiple sclerosis
V Brundula et al.
BRAIN (2002)
Caspase-mediated parkin cleavage in apoptotic cell death
S Kahns et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice
S Zhu et al.
NATURE (2002)
Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia
TM Tikka et al.
JOURNAL OF IMMUNOLOGY (2001)
Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice
DX Chen et al.
NATURE MEDICINE (2000)
Tetracycline affects abnormal properties of synthetic PrP peptides and PrPSc in vitro
F Tagliavini et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
分享论文
